KalVista Pharmaceuticals
KALV
KALV
18 hedge funds and large institutions have $52.2M invested in KalVista Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
3% less capital invested
Capital invested by funds: $54.1M → $52.2M (-$1.84M)
Holders
18
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$2.02M | |
| 2 | +$1.37M | |
| 3 | +$125K | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$11K |
| 5 |
BlackRock
New York
|
+$2.7K |
Top Sellers
| 1 | -$1.19M | |
| 2 | -$11K | |
| 3 | -$10.7K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$7K |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$649 |